Conversely, seven of the downregulated hub genes (TLR4, PECAM1, SELP, CXCL12, VWF, KDR, and CD34) showed both low expression and good prognosis in lung cancer patients (p < 0.05; Fig. 4A–H). This evidence concerns the gene PECAM1 and lung carcinoma.